Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study.
Ryckman, TS; MCQUAID, CF; Cohen, T; Menzies, NA; Kendall, EA;
2024
The Lancet Global health, (2024).12 10 10.1016/S2214-109X(24)00284-5.
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial).
Mangu, C; Cossa, M; Ndege, R; Khosa, C; Leukes, V; De la Torre-Pérez, L; Machiana, A; Kivuma, B; Mnzava, D; Zachariah, C; Manjate, P; Tagliani, E; Schacht, C; Buech, J; Singh, S; Ehrlich, J; Riess, F; Sanz, S; KRANZER, K; Cox, H; Sabi, I; Nguenha, D; Meggi, B; Weisser, M; Ntinginya, N; ... TB-CAPT Consortium,
2024
BMC infectious diseases, (2024).24 1 10.1186/s12879-024-09651-z.
WHO global research priorities for antimicrobial resistance in human health.
Bertagnolio, S; Dobreva, Z; Centner, CM; Olaru, ID; Donà, D; Burzo, S; Huttner, BD; Chaillon, A; Gebreselassie, N; Wi, T; Hasso-Agopsowicz, M; Allegranzi, B; Sati, H; Ivanovska, V; Kothari, KU; Balkhy, HH; Cassini, A; Hamers, RL; Weezenbeek, KV; WHO Research Agenda for AMR in Human Health Collab,;
2024
The Lancet Microbe, (2024).5 11 10.1016/S2666-5247(24)00134-4.
VIVALDI ASCOT and Ethnography Study: protocol for a mixed-methods longitudinal study to evaluate the impact of COVID-19 and other respiratory infection outbreaks on care home residents' quality of life and psychosocial well-being.
Bertini, L; Schmidt-Renfree, N; Blackstone, J; Stirrup, O; Adams, N; Cullen-Stephenson, I; Krutikov, M; Leiser, R; Goscé, L; Henderson, C; Flowers, P; Shallcross, L; Cassell, JA; Cadar, D;
2024
BMJ open, (2024).14 8 10.1136/bmjopen-2024-088685.
Estimating the Impact of Tuberculosis Pathways on Transmission-What Is the Gap Left by Passive Case Finding?.
HORTON, KC; McCaffrey, T; RICHARDS, AS; SCHWALB, A; HOUBEN, RM G J;
2024
The Journal of infectious diseases, (2024).230 5 10.1093/infdis/jiae390.
Improving the contribution of mathematical modelling evidence to guidelines and policy: Experiences from tuberculosis.
MCQUAID, CF; Menzies, NA; HOUBEN, RM G J; Gomez, GB; VASSALL, A; Arinaminpathy, N; Dodd, PJ; WHITE, RG;
2024
Epidemics, (2024).48 100786 10.1016/j.epidem.2024.100786.
Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning.
CRyPTIC consortium,;
2024
PLoS computational biology, (2024).20 8 10.1371/journal.pcbi.1012260.
Correction: The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
Gunsaru, V; Henrion, MY R; MCQUAID, CF;
2024
BMC medicine, (2024).22 1 10.1186/s12916-024-03551-4.
Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.
MCQUAID, CF; Ryckman, TS; Menzies, NA; WHITE, RG; Cohen, T; Kendall, EA;
2024
Emerging infectious diseases, (2024).30 8 10.3201/eid3008.240541.
The International Consensus for Early TB framework (ICE-TB): Implications from a low-incidence setting.
Denholm, JT; Coussens, A; HOUBEN, RM G J; HORTON, KC; Wong, EB; Kendall, EA; Martinez, L; Musvosi, M; Zaidi, SM A;
2024
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2024).28 8 10.5588/ijtld.24.0081.